In painstaking detail today, Pharmac outlined steps taken to manage a controversial anti-epilepsy drug-funding switch, while a UK epilepsy advocate offered the coronial inquest an alternative approach
Communication between people with epilepsy, their doctors and between agencies, around the potential risks of switching brands of anti-epileptic lamotrigine was examined at today’s epilepsy deaths inquest
Hundreds of medications and supplements have been reported to cause liver injury. Gastroenterologist Alan Fraser addresses a few of the commonly implicated agents and the issues they may or may not cause
Pharmac has eased access to highly regarded new type 2 diabetes drugs for Māori and Pacific patients, by requiring they meet only one Special Authority criterion
The arrival of funded empagliflozin has been eagerly awaited by many. As you start prescribing it to patients meeting Pharmac’s new Special Authority criteria, here’s a hypothetical case study illustrating one possible adverse effect to be aware of
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management